BioSpace News Archive

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2019 Healthcare Conference in New York on Thursday, June 6, 2019 at 1:30 p.m. ET.

A range of VIASENSOR gas analyzers from Q.E.D Environmental Systems Inc., are used in medical and dental facility applications, including operating room background nitrous oxide (N2O) levels, piped hospital gas levels, N2O storage leak detection, verification of possible exposure to N2O, and carbon dioxide (CO2) gas level verification for incubator applications.

TFF Pharmaceuticals, Inc. announced it has closed an $8.17 million offering of Series A Preferred Stock.

PureTech Health plc. announced that Daphne Zohar, founder and chief executive officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, at 11:30 AM EDT.

Longboat Clinical is pleased to announce a new partnership with the Avoca Quality Consortium to make an extensive suite of quality management tools available to hospitals and clinics participating in clinical studies.

Rykindo®, Luye Pharma’s innovative, independently developed Extended-Release Microspheres formulation for injection, is one step closer to going on the U.S. market.

ImaginAb, Inc. announces that it is scheduled to present at the following investor and scientific conferences in May and June 2019.

Achieve Life Sciences, Inc. announced that the United States Patent and Trademark Office has granted Achieve a patent on succinate salt of cytisinicline and use thereof.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic collaboration with Debiopharm for the development of a companion diagnostic (CDx) test using its newly-launched Whole Transcriptome Sequencing (WTS) assay for mRNA analysis called MI Transcriptome™

Milestone Pharmaceuticals Inc. announced Joseph G. Oliveto, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference in New York on Thursday, June 6, 2019 at 9:30 a.m. Eastern Time.